PMC:7441777 / 23585-24886
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T38 | 342-350 | Body_part | denotes | backbone | http://purl.org/sig/ont/fma/fma13478 |
T39 | 1099-1110 | Body_part | denotes | amino acids | http://purl.org/sig/ont/fma/fma82739 |
T40 | 1130-1136 | Body_part | denotes | radius | http://purl.org/sig/ont/fma/fma23463 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T70 | 165-173 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T141 | 93-96 | http://purl.obolibrary.org/obo/CLO_0009325 | denotes | TF1 |
T142 | 463-464 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T143 | 495-496 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T144 | 685-686 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T145 | 693-694 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T146 | 701-702 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T147 | 709-710 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T148 | 717-718 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T149 | 725-726 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T150 | 733-734 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T151 | 741-742 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T152 | 752-753 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
T153 | 880-883 | http://purl.obolibrary.org/obo/CLO_0009325 | denotes | TF1 |
T154 | 1128-1129 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T155 | 1142-1143 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | Å |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T337 | 75-85 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T338 | 87-91 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T339 | 110-113 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
T340 | 115-125 | Chemical | denotes | hesperidin | http://purl.obolibrary.org/obo/CHEBI_28775 |
T341 | 127-136 | Chemical | denotes | myricetin | http://purl.obolibrary.org/obo/CHEBI_18152|http://purl.obolibrary.org/obo/CHEBI_58395 |
T343 | 142-155 | Chemical | denotes | quercetagetin | http://purl.obolibrary.org/obo/CHEBI_8695 |
T344 | 351-356 | Chemical | denotes | atoms | http://purl.obolibrary.org/obo/CHEBI_33250 |
T345 | 763-773 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T346 | 780-784 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T347 | 791-794 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
T348 | 823-832 | Chemical | denotes | myricetin | http://purl.obolibrary.org/obo/CHEBI_18152|http://purl.obolibrary.org/obo/CHEBI_58395 |
T350 | 839-852 | Chemical | denotes | quercetagetin | http://purl.obolibrary.org/obo/CHEBI_8695 |
T351 | 859-869 | Chemical | denotes | hesperidin | http://purl.obolibrary.org/obo/CHEBI_28775 |
T352 | 978-987 | Chemical | denotes | myricetin | http://purl.obolibrary.org/obo/CHEBI_18152|http://purl.obolibrary.org/obo/CHEBI_58395 |
T354 | 1099-1110 | Chemical | denotes | amino acids | http://purl.obolibrary.org/obo/CHEBI_33709 |
T355 | 1099-1104 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T356 | 1105-1110 | Chemical | denotes | acids | http://purl.obolibrary.org/obo/CHEBI_37527 |
T357 | 1153-1162 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
571 | 104-108 | Gene | denotes | TF2b | Gene:2959 |
572 | 176-180 | Gene | denotes | RdRp | Gene:43740578 |
573 | 758-762 | Gene | denotes | RdRp | Gene:43740578 |
574 | 775-779 | Gene | denotes | RdRp | Gene:43740578 |
575 | 786-790 | Gene | denotes | RdRp | Gene:43740578 |
576 | 796-800 | Gene | denotes | RdRp | Gene:43740578 |
577 | 801-805 | Gene | denotes | TF2b | Gene:2959 |
578 | 807-811 | Gene | denotes | RdRp | Gene:43740578 |
579 | 818-822 | Gene | denotes | RdRp | Gene:43740578 |
580 | 834-838 | Gene | denotes | RdRp | Gene:43740578 |
581 | 854-858 | Gene | denotes | RdRp | Gene:43740578 |
582 | 875-879 | Gene | denotes | RdRp | Gene:43740578 |
583 | 956-960 | Gene | denotes | RdRp | Gene:43740578 |
584 | 973-977 | Gene | denotes | RdRp | Gene:43740578 |
585 | 165-175 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
586 | 75-85 | Chemical | denotes | remdesivir | MESH:C000606551 |
587 | 87-91 | Chemical | denotes | EGCG | MESH:C045651 |
588 | 115-125 | Chemical | denotes | hesperidin | MESH:D006569 |
589 | 127-136 | Chemical | denotes | myricetin | MESH:C040015 |
590 | 763-773 | Chemical | denotes | remdesivir | MESH:C000606551 |
591 | 342-356 | Disease | denotes | backbone atoms |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T9 | 93-96 | GlycoEpitope | denotes | TF1 | http://www.glycoepitope.jp/epitopes/AN0049 |
T10 | 880-883 | GlycoEpitope | denotes | TF1 | http://www.glycoepitope.jp/epitopes/AN0049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T232 | 0-284 | Sentence | denotes | The 150 ns production simulations carried out for nine systems (complex of remdesivir, EGCG, TF1, TF2a, TF2b, TF3, hesperidin, myricetin, and quercetagetin with the SARS-CoV-2 RdRp) were stable on the basis of the potential energy and total energy (data not shown) of those complexes. |
T233 | 285-466 | Sentence | denotes | Subsequently, the root-mean-square deviations (RMSDs) of backbone atoms relative to their respective initial positions were calculated for each complex and are shown in Figure 3(A). |
T234 | 467-634 | Sentence | denotes | It is evident from Figure 3(A) that all the nine studied systems drifted from their initial positions during the first 50 ns, and after that, they reached equilibrium. |
T235 | 635-918 | Sentence | denotes | The average RMSD values were estimated to be 2.30 Å, 2.45 Å, 1.87 Å, 2.28 Å, 1.68 Å, 2.47 Å, 1.90 Å, 2.03 Å and 1.88 Å for RdRp/remdesivir, RdRp/EGCG, RdRp/TF3, RdRp/TF2b, RdRp/TF2a, RdRp/myricetin, RdRp/quercetagetin, RdRp/hesperidin, and RdRp/TF1 complexes, respectively (Table 3). |
T236 | 919-1020 | Sentence | denotes | The least deviation was observed for RdRp/TF2a, while RdRp/myricetin displayed the highest deviation. |
T237 | 1021-1242 | Sentence | denotes | We also investigated structural variations in the binding site, including all amino acids that fall within a radius of 5 Å from the inhibitor, and the same trend was observed (Figure S2A in the Supplementary Information). |
T238 | 1243-1301 | Sentence | denotes | Overall, this suggests the convergence of our simulations. |